1,910
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Polyunsaturated fatty acid-based targeted nanotherapeutics to enhance the therapeutic efficacy of docetaxel

, , , , , , , , , & show all
Pages 1262-1272 | Received 13 Jul 2017, Accepted 25 Aug 2017, Published online: 09 Sep 2017

References

  • Berquin IM, Edwards IJ, Chen YQ. (2008). Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 269:363–77.
  • Bougnoux P, Hajjaji N, Maheo K, et al. (2010). Fatty acids and breast cancer: sensitization to treatments and prevention of metastatic re-growth. Prog Lipid Res 49:76–86.
  • Cao D, Luo J, Zang W, et al. (2016). Gamma-linolenic acid suppresses NF-κΒ signaling via CD36 in the lipopolysaccharide-induced inflammatory response in primary goat mammary gland epithelial cells. Inflammation 39:1225–37.
  • Choi JY, Ramasamy T, Tran TH, et al. (2015). Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth. J Mater Chem B 3:408–16.
  • Choi JY, Thapa KT, Yong CS, et al. (2016). Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. J Pharm Invest 46:325–39.
  • De Pauw I, Wouters A, Van den Bossche J, et al. (2016). Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: potential impact in colorectal cancer. Pharmacol Ther 166:71–83.
  • Esfandyari-Manesh M, Darvishi B, Ishkuh FA, et al. (2016). Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: characterization and cellular cytotoxicity. Mater Sci Eng C Mater Biol Appl 62:626–33.
  • Guo S, Huang L. (2014). Nanoparticles containing insoluble drug for cancer therapy. Biotechnol Adv 32:778–88.
  • He C, Lu J, Lin W. (2015). Hybrid nanoparticles for combination therapy of cancer. J Control Release 219:224–36.
  • Jain A, Thakur K, Sharma G, et al. (2016). Fabrication, characterization and cytotoxicity studies of ionically cross-linked docetaxel loaded chitosan nanoparticles. Carbohydr Polym 137:65–74.
  • Jiang S, Gong X, Zhao X, et al. (2015). Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles. Drug Deliv 22:206–13.
  • Jin H, Pi J, Yang F, et al. (2016). Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep 6:30782.
  • Kajita M, Morishita M, Takayama K, et al (2000). Enhanced enteral bioavailability of vancomycin using water-in-oil-in-water multiple emulsion incorporating highly purified unsaturated fatty acid. J Pharm Sci 89:1243–52.
  • Kim DW, Ramasamy T, Choi JY, et al. (2014). The influence of bile salt on the chemotherapeutic response of docetaxel-loaded thermosensitive nanomicelles. Int. J. Nanomed 9:3815.
  • Kim JS. (2016). Liposomal drug delivery system. J Pharm Invest 46:387–92.
  • Leamon CP, Reddy JA. (2004). Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127–41.
  • Lee ES, Youn YS. (2016). Albumin-based potential drugs: focus on half-life extension and nanoparticle preparation. J Pharm Invest 46:305–15.
  • Liu Z, Zhong Z, Peng G, et al. (2009). Folate receptor mediated intracellular gene delivery using the charge changing solid lipid nanoparticles. Drug Deliv 16:341–7.
  • Manning BD, Cantley LC. (2007). AKT/PKB signaling: navigating downstream. Cell 129:1261–74.
  • Marusyk A, Almendro V, Polyak K. (2012). Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–34.
  • Pawar H, Surapaneni SK, Tikoo K, et al. (2016). Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats. Drug Deliv 23:1453–68.
  • Ramasamy T, Poudel BK, Ruttala H, et al. (2016). Cationic drug-based self-assembled polyelectrolyte complex micelles: physicochemical, pharmacokinetic, and anticancer activity analysis. Colloids Surf B Biointerfaces 146:152–60.
  • Ramasamy T, Tran TH, Choi JY, et al. (2014). Layer-by-layer coated lipid-polymer hybrid nanoparticles designed for use in anticancer drug delivery. Carbohydr Polym 102:653–61.
  • Ramasamy TG, Haidar ZS. (2011). Formulation, characterization and cytocompatibility evaluation of novel core-shell solid lipid nanoparticles for the controlled and tunable delivery of a model protein. J Bionanosci 5:143–54.
  • Ramasamy T, Ruttala HB, Chitrapriya N, et al. (2017). Engineering of cell microenvironment-responsive polypeptide nanovehicle co-encapsulating a synergistic combination of small molecules for effective chemotherapy in solid tumors. Acta Biomater 48:131–143.
  • Ruttala HB, Ramasamy T, Shin BS, et al. (2017). Layer-by-Layer Assembly of Hierarchical Nanoarchitectures to Enhance the Systemic Performance of Nanoparticle Albumin-bound Paclitaxel. Int J Pharm 519:11–21.
  • Ren G, Liu D, Guo W, et al. (2016). Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation. Drug Deliv 23:1272–81.
  • Ribeiro IA, Faustino CM, Guerreiro PS, et al. (2015). Development of novel sophorolipids with improved cytotoxic activity toward MDA-MB-231 breast cancer cells. J Mol Recognit 28:155–65.
  • Roy J, Oliveira LT, Oger C, et al. (2015). Polymeric nanocapsules prevent oxidation of core-loaded molecules: evidence based on the effects of docosahexaenoic acid and neuroprostane on breast cancer cells proliferation. J Exp Clin Cancer Res 34:155.
  • Sarisozen C, Pan J, Dutta I, et al. (2017). Polymers in the co-delivery of siRNA and anticancer drugs to treat multidrug-resistant tumors. J Pharm Invest 47:37–49.
  • Shi J, Zhang J, Shen Y, et al. (2015). Arginine-stabilized mPEG-PDLLA (50/50) polymeric micelles of docetaxel by electrostatic mechanism for tumor-targeted delivery. Drug Deliv 22:168–81.
  • Sundaramoorthy P, Ramasamy T, Mishra SK, et al. (2016). Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells. Acta Biomater 42:220?231.
  • Siddiqui RA, Harvey KA, Xu Z, et al. (2011). Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects. BioFactors 37:399–412.
  • Sriraman SK, Salzano G, Sarisozen C, et al. (2016). Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid. Eur J Pharm Biopharm 105:40–9.
  • Tang J, Li L, Howard CB, et al. (2015). Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells. J Mater Chem B Mater Biol Med 3:6805–12.
  • Tiwari SB, Amiji MM (2006). Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J Nanosci Nanotechnol 6:3215–21.
  • Vander Heiden MG, Thompson CB. (1999). Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis? Nat Cell Biol 1:E209–16.
  • Vyas TK, Shahiwala A, Amiji MM. (2008). Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int J Pharm 347:93–101.
  • Wang Y, Sun J, Zheng R, et al. (2016). Regulatory T cells are an important prognostic factor in breast cancer: a systematic review and meta-analysis. Neoplasma 63:789–98.
  • Xu Y, Qian SY. (2014). Anti-cancer activities of ω-6 polyunsaturated fatty acids. Biomed J 37:112–19.
  • Youn K, Lee J, et al. (2014). Biological evaluation andin silicodocking study of γ-linolenic acid as a potential BACE1 inhibitor. J Funct Foods 10:187–91.
  • Zhao P, Astruc D. (2012). Docetaxel nanotechnology in anticancer therapy. Chem Med Chem 7:952–72.
  • Zhu D, Tao W, Zhang H, et al. (2016). Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater 30:144–54.